Clearstead Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.65K | Hold |
191
| – | – | ﹤0.01% | 2121 |
|
|
2025
Q1 | $3.97K | Sell |
191
-427
| -69% | -$8.87K | ﹤0.01% | 1784 |
|
|
2024
Q4 | $14.6K | Sell |
618
-57
| -8% | -$1.34K | ﹤0.01% | 1477 |
|
|
2024
Q3 | $17.3K | Buy |
675
+82
| +14% | +$2.1K | ﹤0.01% | 1460 |
|
|
2024
Q2 | $13.9K | Hold |
593
| – | – | ﹤0.01% | 1467 |
|
|
2024
Q1 | $15.6K | Hold |
593
| – | – | ﹤0.01% | 981 |
|
|
2023
Q4 | $19.5K | Sell |
593
-5,780
| -91% | -$190K | ﹤0.01% | 947 |
|
|
2023
Q3 | $178K | Buy |
6,373
+5,780
| +975% | +$161K | 0.01% | 593 |
|
|
2023
Q2 | $20.2K | Hold |
593
| – | – | ﹤0.01% | 896 |
|
|
2023
Q1 | $17.8K | Hold |
593
| – | – | ﹤0.01% | 867 |
|
|
2022
Q4 | $16.7K | Hold |
593
| – | – | ﹤0.01% | 827 |
|
|
2022
Q3 | $19K | Sell |
593
-8,722
| -94% | -$279K | ﹤0.01% | 774 |
|
|
2022
Q2 | $293K | Sell |
9,315
-1,333
| -13% | -$41.9K | 0.02% | 322 |
|
|
2022
Q1 | $489K | Sell |
10,648
-20
| -0.2% | -$918 | 0.03% | 269 |
|
|
2021
Q4 | $653K | Sell |
10,668
-5,153
| -33% | -$315K | 0.04% | 221 |
|
|
2021
Q3 | $1.18M | Buy |
15,821
+1,700
| +12% | +$127K | 0.09% | 153 |
|
|
2021
Q2 | $1.31M | Buy |
14,121
+3,398
| +32% | +$314K | 0.1% | 144 |
|
|
2021
Q1 | $951K | Buy |
10,723
+9,310
| +659% | +$826K | 0.08% | 160 |
|
|
2020
Q4 | $132K | Buy |
+1,413
| New | +$132K | 0.01% | 371 |
|